Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04226924Phase 2Withdrawn
Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
Oculopharyngeal Muscular Dystrophy
PrincipalinvestigatorStart date: 2017-06-15

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

McGill University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sarah Youssof, MD, MS

New Mexico Neuromuscular Center

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Sophie PS Perie, PhD

APHP

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Frederic MF Mouriaux, PhD

Rennes University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Karen BH Pedersen, Bsc.med.

Neuromuscular Research Unit, Rigshospitalet, Denmark

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Itzhak Braverman, Doctor (MD)

Hillel Yaffe Medical Center, Israel

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Gerald Pfeffer, MD, PhD

University of Calgary

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Françoise CF Chapon, PhD

University Hospital, Caen

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Jean Lacau-Saint Guily, MD, PH

Assistance Publique - Hôpitaux de Paris

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Milan R. Amin, M.D.

NYU Langone Health

Moderately Similar
1 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Emily Plowman, PhD

University of Florida

Moderately Similar
6 trials

Shared therapeutic areas:

Muscular Dystrophy, Oculopharyngeal
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04226924Phase 2PrincipalInvestigator

Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose

Oculopharyngeal Muscular Dystrophy
Withdrawn
NCT02015481Phase 2PrincipalInvestigator

Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients

Oculopharyngeal Muscular Dystrophy
Completed

All 2 trials loaded